Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

類似資料

• Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
  著者:: Chen Liu MD, PhD, 等
  出版事項: (2020-04-01)
• Lewis antigen-negative pancreatic cancer: An aggressive subgroup
  著者:: Liu, Chen, 等
  出版事項: (2020)
• Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
  著者:: Qian, Yunzhen, 等
  出版事項: (2020)
• Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
  著者:: Gong, Yitao, 等
  出版事項: (2020)
• High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
  著者:: Gong, Yitao, 等
  出版事項: (2021)